Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Bolt Biotherapeutics, Inc.”

7 pharma patents match "Bolt Biotherapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Bolt Biotherapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Bolt Biotherapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12325750

    Anti-Dectin-2 antibodies and methods of using

    Bolt Biotherapeutics, Inc. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted

  2. US 11753474

    Anti-Dectin-2 antibodies

    Bolt Biotherapeutics, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  3. US 11654199

    Thienoazepine immunoconjugates, and uses thereof

    Bolt Biotherapeutics, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted

  4. US 11547761

    Antibody adjuvant conjugates

    Bolt Biotherapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  5. US 11400164

    Immunoconjugates targeting HER2

    Bolt Biotherapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  6. US 11110178

    Antibody adjuvant conjugates

    Bolt Biotherapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  7. US 10675358

    Antibody adjuvant conjugates

    Bolt Biotherapeutics, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.